Med Sheet Digoxin
docx
keyboard_arrow_up
School
Texas A&M International University *
*We aren’t endorsed by this school
Course
MISC
Subject
Medicine
Date
Apr 3, 2024
Type
docx
Pages
2
Uploaded by LieutenantSardineMaster1088
Part 2 Patient-Specific Information
DRUG
Time Due:
Dose:
Frequency:
Route:
Administration Instructions (specific to route):
REASON
What is this medication's goal/expected outcome (therapeutic effect)?
What evidence from the patient’s chart supports the need for this medication? (i.e., vitals signs, assessment, lab data, medical history, etc.). SAFETY
Is this a home medication? If Y is the dose the same?
Is the ordered dose safe (according to the safe/usual dose range)?
What labs should be assessed prior to administration? Include lab name and client’s
lab results (even if normal).
Is a dose adjustment required based on the client’s lab results?
Based on your client’s other medications, are there any drug-to-drug interactions or IV incompatibilities? Does your client have any of the known contraindications, black box warnings, or adverse effects associated with this medication? (
Support
with evidence) If Y, how will you manage these risks?
Is the drug safe to administer? Y/N and Why? (
Support
with evidence) EVALUATION
Did this medication achieve the desired outcome (provide evidence)?
What assessment data and labs need to be continuously monitored after the drug is administered?
FACULTY
SIGNATURE
Part 1 Drug-Specific Information (Permission to reuse this portion of form in all courses)
Name
(Generic/Brand)
Digoxin Class (Pharm/Therapeutic)
Pharm: Digitalis glycosides Therapeutic: Antiarrhythmics, inotropic Mechanism of Action
Increases the force of myocardial contraction. Prolongs refractory period of the AV nodes
Increases cardiac output and slowing of the heart rate Onset & Peak
PO: Onset 30-120mins Peak: 2-8hrs
IM: Onset 30mins Peak: 4-6hrs IV: Onset 5-30mins Peak: 1-4 hrs
Indications
Heart failure, atrial fibrillation, and atrial flutter
Drug Library safe/usual
dose range
IV, IM (Adults): digitalizing dose – 0.5 – 1 mg given as 50% of the dose initially and one quarter of the initial dose in each of 2 subsequent doses at 6-12 hr intervals PO (Adults): digitalizing dose – 0.75 – 1.5mg given as 50% of the dose initially and one quarter of the initial dose in each of 2 subsequent doses at 6-12 hrs intervals. Maintenance dose – 0.125 – 0.5mg/day depending on the patients lean body weight, renal function, and serum levels Drug-to-Drug Interactions
IV Incompatibilities
Thiazide and loop diuretics, piperacillin/tazobactam, amphotericin B, corticosteroids, and excessive use of laxatives may cause hypokalemia which may increase
risk of toxicity
Most Common & Serious
Adverse Effects
Arrythmias, bradycardia, ECG changes, AV block, SA block, blurred vision, anorexia, nausea, vomiting, fatigue, weakness Contraindications
Black Box Warnings
Hypersensitivity, uncontrolled ventricular arrythmias, AV block
Caution in: hypokalemia (increases risk of digoxin toxicity), hypercalcemia (increases risk of toxicity), hypomagnesemia (risk of toxicity), diuretic use, renal impairment, hypothyroidism Patient Education (Basic Summary)
Take med as directed, teach patient to take pulse and to contact HCP before taking med if pulse is <60 or >100. Review S/S of digitalis toxicity, keep digoxin tablets in their original container and not to mix in pill boxes
Your preview ends here
Eager to read complete document? Join bartleby learn and gain access to the full version
- Access to all documents
- Unlimited textbook solutions
- 24/7 expert homework help